Involvement of l-type amino acid transporter 1 in the transport of gabapentin into human placental choriocarcinoma cells.

DOI IR (HANDLE) HANDLE Web Site Web Site View 1 Remaining Hide 3 Citations 38 References Open Access

Description

Gabapentin (GBP) is a widely used antiepileptic drug, with potential for use in the treatment of epilepsy in pregnant women. Although studies have examined GBP transport mechanisms across the blood-brain barrier, kidney, and intestine, the mechanism in the placenta has not been fully elucidated. We previously reported that GBP accumulates at high concentrations in human placental choriocarcinoma BeWo cells. The purpose of this study was to examine the transport mechanism of GBP in placental choriocarcinoma cells (BeWo and JEG-3), and to identify the carrier involved. High concentrations of intracellular GBP accumulations were also found in JEG-3 cells. A kinetic analysis showed that a single carrier system was involved in the uptake of GBP. Furthermore, substrates for l-type amino acid transporter (LAT) and siRNAs targeted to LAT1 significantly decreased GBP uptake. Our observations from this study suggest that LAT1 is the main contributor to GBP transport in placental choriocarcinoma cells.

Journal

Citations (3)*help

See more

References(38)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top